Swinglowandslow
Well-known member
The NHS, through NICE, routinely reviews new medicines using Quality Adjusted Life Years. In brief, this combines the effect on quality of life with the years of live saved by treatment. So, as an aside, the NHS is institutionally ageist, because treatments offered to older people save fewer years than those offered to younger people, and hence are less good value in the older people. Anyway, applying the same equation to Covid, an argument could emerge that the value of vaccines ra optimised when used in people at the older ages of working life, and who still have dependents, because the effect of illness or death costs a lot more years of life, affects family members and the economy. There was a report in the media about an old dear with advanced dementia getting her vaccine. Now, I may be demented one day, possibly have started already, but the quality of life benefits in vaccinating people with dementia are next to zilch. Sounds harsh, but that is how rationing in the NHS already works.
I haven't run the numbers, but offer this just to challenge the rather one dimensional idea that people at the highest risk of death is the best way to prioritise. As a separate aside, if that formula was really true, men would get vacc'd before women 5 years younger, and BAME would get vacc'd a similar period before white prople. And BAME men would get vacc'd 10 years younger than white women. So discrimination by age is OK, but not by gender or ethnicity.
Hmmm, I suppose that's a very good reason why the Queen and Prince Phillip don't rely on the NHS??